Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004663472 | SCV005161216 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-05-13 | criteria provided, single submitter | clinical testing | The c.444_445delACinsTCTATGG pathogenic mutation, located in coding exon 5 of the SDHB gene, results from the deletion of two nucleotides and insertion of 7 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.Q149Lfs*11). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV005249712 | SCV005895918 | pathogenic | Paragangliomas 4 | 2024-10-23 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |